Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Filing Date
Nov 30, 2020
Document Date
Nov 30, 2020
Form Description
S-3ASR
Filing Group
Registration Statements
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.